Erbao Zhang
Overview
Explore the profile of Erbao Zhang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1756
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dai J, Lu X, Zhang C, Qu T, Li W, Su J, et al.
Mol Cancer
. 2025 Mar;
24(1):79.
PMID: 40089784
Background: Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are remarkably effective for treating EGFR-mutant non-small cell lung cancer (NSCLC). However, patients inevitably develop acquired drug resistance, resulting in recurrence or...
2.
Zhang C, Zhou W, Xu H, Xu J, Li J, Liu X, et al.
Oncogene
. 2025 Feb;
PMID: 40011576
Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) remains a major challenge in the treatment of lung cancer. Cancer associated fibroblasts (CAFs) play a key role in...
3.
Qu T, Zhang C, Lu X, Dai J, He X, Li W, et al.
Nat Commun
. 2025 Feb;
16(1):1986.
PMID: 40011431
As a well-known cancer risk region, the 8q24 locus is frequently amplified in a variety of solid tumors. Here we identify a pseudogene-derived oncogenic lncRNA, ZNF252P, which is upregulated in...
4.
Huang Q, Chen H, Yin D, Wang J, Wang S, Yang F, et al.
NPJ Precis Oncol
. 2024 Jan;
8(1):24.
PMID: 38291241
Metabolic reprogramming has been observed in cancer metastasis, whereas metabolic changes required for malignant cells during lymph node metastasis of esophageal squamous cell carcinoma (ESCC) are still poorly understood. Here,...
5.
Zhang E, Sun Q, Zhang C, Ma H, Zhang J, Ding Y, et al.
Cancer Lett
. 2024 Jan;
585:216646.
PMID: 38262497
Approximately 51 non-small-cell lung cancer (NSCLC) risk loci have been identified by genome-wide association studies (GWASs). We conducted a high throughput RNA-interference (RNAi) screening to identify the candidate causal genes...
6.
Hua T, Zhang C, Fu Y, Qin N, Liu S, Chen C, et al.
Mol Carcinog
. 2023 Dec;
63(3):538-548.
PMID: 38051288
N -methyladenosine (m A) modification has been identified as one of the most important epigenetic regulation mechanisms in the development of human cancers. However, the association between m A-associated single-nucleotide...
7.
Zhang Y, Gao Y, Li F, Qi Q, Li Q, Gu Y, et al.
Carcinogenesis
. 2023 Nov;
45(1-2):23-34.
PMID: 37950445
Long non-coding RNAs (lncRNAs) serve as vital candidates to mediate cancer risk. Here, we aimed to identify the risk single-nucleotide polymorphisms (SNPs)-induced lncRNAs and to investigate their roles in gastric...
8.
Hu X, Wu J, Feng Y, Ma H, Zhang E, Zhang C, et al.
Clin Transl Med
. 2023 Sep;
13(9):e1361.
PMID: 37658588
Background: Super enhancers (SE) play pivotal roles in cell identity and diseases occur including tumorigenesis. The depletion of SE-associated lncRNA transcripts, also known as super-lncRNA, causes the activity of SE...
9.
Wang Y, Ding Y, Liu S, Wang C, Zhang E, Chen C, et al.
Am J Hum Genet
. 2023 Aug;
110(9):1574-1589.
PMID: 37562399
Splicing quantitative trait loci (sQTLs) have been demonstrated to contribute to disease etiology by affecting alternative splicing. However, the role of sQTLs in the development of non-small-cell lung cancer (NSCLC)...
10.
Cui Y, Li J, Zhang P, Yin D, Wang Z, Dai J, et al.
J Exp Clin Cancer Res
. 2023 Jun;
42(1):146.
PMID: 37303063
Background: Invasive adenocarcinoma (IAC), which is typically preceded by minimally invasive adenocarcinoma (MIA), is the dominant pathological subtype of early-stage lung adenocarcinoma (LUAD). Identifying the molecular events underlying the progression...